A dose-escalation and signal-generating study of the immunocytokine L19-IL2 in combination with dacarbazine for the therapy of patients with metastatic melanoma. (Q40307989)
Jump to navigation
Jump to search
scientific article published on 25 October 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A dose-escalation and signal-generating study of the immunocytokine L19-IL2 in combination with dacarbazine for the therapy of patients with metastatic melanoma. |
scientific article published on 25 October 2011 |
Statements
A dose-escalation and signal-generating study of the immunocytokine L19-IL2 in combination with dacarbazine for the therapy of patients with metastatic melanoma (English)
Benjamin Weide
Annette Pflugfelder
Gianluca Spitaleri
Antonella Romanini
Reinerio González-Iglesias
Annaelisa Tasciotti
Kathrin Schwager
Valeria Lovato
Manuela Kaspar
Eveline Trachsel
Hans D Menssen
25 October 2011